relatively 
                                                   low for 
                                                   mammalian 
                                                   cell use. 
*FMv6*       Nov 2019 WBC         60kb+   15.5     FM 
                                  to 56   -21.1    temperature 
                                                   protocol 
                                                   changes 
                                                   improved N50 
                                                   & yield 
                                                   results in 
                                                   more usable 
                                                   DNA, tuneable 
                                                   N50/throughpu 
                                                   t equation 
                                                   for mammalian 
                                                   cells - no 
                                                   difference to 
                                                   v5 for 
                                                   bacteria. 
*FMv7*       -        -           -       -        Undisclosed 
*FMv8*       Oct 2020 Bacteria    45.8    25.6     Better cell 
                                                   re-suspension 
                                                   to improve 
                                                   sequencing 
                                                   yield further 
                                                   (>20%) at 
                                                   high N50 
                                                   leads to high 
                                                   DNA recovery, 
                                                   larger volume 
                                                   of bacteria 
                                                   use possible. 
                                                   More DNA per 
                                                   run or more 
                                                   DNA for more 
                                                   runs. 
*FMv8*       Nov 2020 Bacteria    36.7    28.5     Optimised 
                                                   Yield at high 
                                                   N50. Total 
                                                   raw data 
                                                   yield is 30Gb 
                                                   pre Q7 cut 
                                                   off 
 
FM = Fire Monkey. WBC = white blood cells. Source; RevoluGen internal records. 
 
*Figure 3 
 
Cheaper $/GB sequencing results from using Fire Monkey* 
 
Link to graphic: Figure3.pdf (b3cnewswire.com) [3] 
 
*Sequencing *Platform* *Data      *N50 Read *Max *Throughput/ *Throughput/ *Cost/Gb 
Technology*            type*      Length*   Read flow cell    flow cell    ($/Gb)* 
                                            Leng (Gb) Mean*   (Gb) Max* 
                                            th* 
*Pacific    Sequel II  CLR        30-60     >200 50-100       160          13-26 
Biosciences 
(PacBio)* 
*Oxford     MinION     Long       10-60     >1,0 2-20         30           50-500 
Nanopore                                    00 
Technologie 
s (ONT)* 
*Illumina   NovaSeq    Single-end 0.05-0.25 0.25 65-3,000     >3,000       10-35 
(ILMN)*     6000 
*Fire       Sequel II  CLR        25        n/a  139          n/a          9.4 
Monkey use 
+* 
*Fire       MinION     Long       45.8      n/a  25.6         n/a          39.1 
Monkey use 
+* 
*Fire       MinION     Long       36.7      n/a  28.5         n/a          35.1 
Monkey use 
+* 
 
CLR = continuous long-read. Adapted from Logsdon _et al_ 2020 Long Read Human 
Genome Sequencing and its Applications. Source; Nature Review Genetics (21) 597-614 
plus RevoluGen data. All cost estimates exclude the cost of labour, 
instrumentation, maintenance, and computer resources. 
 
-Ends- 
 
*About RevoluGen* 
RevoluGen is a privately held scientific research and development company 
commercialising molecular tools with a specific focus on rapidly extracting long 
and pure DNA fragments from cells. 
 
RevoluGen's Nucleic Acid Isolation and Purification (NAIP) products have particular 
applications in long-read DNA sequencing for genome assembly and long-range PCR. 
Fire Monkey significantly improves long-read sequencing results by extracting 
long-fragment DNA with a simultaneous size selection function built into the 
protocol that minimises the small-fragment DNA contamination. Used independently, 
the size selection protocol of Fire Flower can improve the molecular ratio of any 
extraction kit and is compatible with all sequencing technologies. 
 
The Company headquarters, R&D, manufacturing and direct customer sales and support 
are based in the UK. RevoluGen serves customers worldwide and has secured 
agreements with world-leading molecular biology tools companies including Merck 
KGaA (sales), Cytiva (manufacturing), Tecan (automation) and A4P (logistics). 
 
For more information, please visit www.revolugen.co.uk [4]. *Follow us on *Twitter 
[5] *and *LinkedIN [6] 
 
*For more information or to arrange media interviews please contact:* 
 
Sue Charles, Head Corporate Communications and Investor Relations, RevoluGen 
 
+44 (0)7968 726585, sue.charles59@outlook.com 
 
2020-11-30 Dissemination of a Corporate News, transmitted by DGAP - a service of 
EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
The DGAP Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
1151356 2020-11-30 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=e8fc3a6d6dbdb83f295a078425dd2f50&application_id=1151356&site_id=vwd&application_name=news 
2: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=d8b7a4b597c83d41f7cdcca7380f63a7&application_id=1151356&site_id=vwd&application_name=news 
3: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=bbaabc2897daa92313217de64434cf6a&application_id=1151356&site_id=vwd&application_name=news 
4: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=00d8cd86da2239df1b8aedceff6a7501&application_id=1151356&site_id=vwd&application_name=news 
5: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=083a67977199a84669e0131c2cbcffd3&application_id=1151356&site_id=vwd&application_name=news 
6: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=06bd75b67e4f7b64ee417a1d8e1e7a28&application_id=1151356&site_id=vwd&application_name=news

(END) Dow Jones Newswires

November 30, 2020 03:00 ET (08:00 GMT)